L'BEL SUPREMACIE NX JOUR Replenishing Treatment Daytime Face Cream SPF 15 Normal To Dry Skin

Manufacturer
Ventura Corporation, LTD | MF Productions
Effective date
2012-03-28
Label type
HUMAN OTC DRUG LABEL
Version
2
Source
full-release
Hydrated at
2026-05-31 22:31:21

Label at a glance#

ProductLBEL SUPREMACIE NX JOUR Replenishing Treatment Daytime Face SPF 15 Normal To Dry Skin
Active ingredientENSULIZOLE, HOMOSALATE, OCTINOXATE, OXYBENZONE
Label structure9 sections

Indications and uses

Helps prevent sunburn.

Label contents#

Full prescribing information#

Active Ingredients

OTC - ACTIVE INGREDIENT SECTION

ENSULIZOLE (2.0%)
HOMOSALATE (2.0%)
OCTINOXATE (7.5%)
OXYBENZONE (4.0%)

Uses

INDICATIONS & USAGE SECTION

  • Helps prevent sunburn.

Warnings

WARNINGS SECTION

  • Skin Cancer / Skin Aging Alert:  Spending time in the sun increases your risk of skin cancer and early skin aging. This product has been shown only to help prevent sunburn, not skin cancer or early skin aging.
  • For external use only.

When using this product

OTC - DO NOT USE SECTION

keep out of eyes.  Rinse with water to remove.

Stop use and ask a doctor if

OTC - STOP USE SECTION

rash occurs.

Keep out of reach of children.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

If swallowed, get medical help or contact a Poison Control Center right away.

Directions

DOSAGE & ADMINISTRATION SECTION

  • Apply liberally and evenly 15 minutes before sun exposure.
  • Reapply at least every 2 years.
  • Use a water resistant sunscreen if swimming or sweating.
  • Children under 6 months of age:  Ask a doctor.

Other Information

SPL UNCLASSIFIED SECTION

  • Protect the product in this container from excessive heat and direct sun.
  • Use in the morning after cleanser and toner. Apply a small quantity with your fingertips, spreading it over your face with rising, circular movements. Message in gently to help facilitate absorption.

Inactive Ingredients

INACTIVE INGREDIENT SECTION

Aqua (water), pisum sativum extract (pisum sativum (pea) extract), glycerin, cetyl alcohol, cyclopentasiloxane, triethanolamine, c12-15 alkyl benzoate, cyclohexasiloxane, glyceryl stearate, stearic acid, phenoxyethanol,polyacrylamide, erythritol,parfum (fragrance), peg-75 stearate, sodium polystyrene sulfonate,methylparaben, trifolium pratense flower extract(trifolium pratense (clover) flower extract), c13-14 isoparaffin,sorghum bicolor stalk juice, propylparaben, xanthan gum, ceteth-20,steareth-20, butylene glycol, laureth-7, acrylates/c10-30 alkyl acrylate crosspolymer, tetrasodium edta, dimethicone, butylparaben, hydrolyzed algin, ethylparaben, chlorella vulgaris extract, lecithin,  maris aqua (sea water), isobutylparaben, carbomer, laureth-23, laureth-4, homarine hcl, ci 19140 (yellow 5),ci 14700 (red 4), biotinoyl tripeptide-1, ci 42090 (blue 1).

Purpose

OTC - PURPOSE SECTION

Sunscreen

EXPERT ROUTINE L'BEL

SPL UNCLASSIFIED SECTION

L'Bel presents Expert Routine, a skin care program with two steps that work together for enhanced results:

   1. Cleanse the skin according to its needs
   2. Nourish according to the age.

SUPREMACIE NX JOUR
replenishing daytime face cream SPF 15

L'Bel, fully specialized in cosmetic facial treatment, presents the latest worldwide exclusive:  the new Supremacie NX line of replenishing cosmetic treatments improved for women after age 40.

Dazzling beauty for women

The moisturizing formula of Supremacie NX Jour, Offers enhanced results:

  • Immediate, strong and long-lasting hydration in the areas where the face needs it most.
  • Visibly diminishes the appearance of wrinkles.
  • Uncovers skin that looks more firm.

A sensation of well-being that pervades the senses

Its rich and creamy texture, ideal for absorption has been specially created to provide a pleasant sensation of softness and comfort. Its exquisite fragrance rich in essences awakens the skin with new and pleasant emotions.

In two options according to your skin's needs:

  •  SUPREMACIE NX JOUR - replenishing daytime face cream SPF 15 Normal to Dry Skin

  •  SUPREMACIE NX JOUR - replenishing daytime face cream SPF 15 Normal to Oily Skin

USES: Helps prevent sunburn.

WARNINGS: Skin Cancer / Skin Aging Alert: Spending time in the sun increases your risk of skin cancer and early skin aging.  This product has been shown only to help prevent sunburn, not skin cancer or early skin aging. For external use only. Do not use on damaged or broken skin. When using this product keep out of eyes. Rinse with water to remove. Stop use and ask a doctor if rash occurs. Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

Directions: Apply liberally and evenly 15 minutes before sun exposure. Reapply at least every 2 hours.Use a water resistant sunscreen if swimming or sweating. Children under 6 months of age:  Ask a doctor.

Other information: Protect the product in this container from excessive heat and direct sun. Use in the morning after cleanser and toner. Apply a small quantity with your fingertips, spreading it over your face with rising, circular movements. Message in gently to help facilitate absorption.

  • HYPOALLERGENIC
  • DERMATOLOGICALLY AND CLINICALLY TESTED

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

L'BEL
SUPREMACIE NX JOUR

replenishing daytime face cream SPF 15
normal to dry skin

50 g e (1.7 oz..)

US: Dist. by Ventura International Ltd.  DBA Belcorp USA, San Francisco, CA 94111.

P.R.: Dist. by Ventura Corporation Ltd. San Juan, Puerto Rico 00926  MADE IN FRANCE.

LBEL SUPREMACIE NX JOUR Replenishing Treatment Daytime Face Cream SPF 15 Normal To Dry Skin

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL


Supremacie NX JourSupremacie NX Jour


Supremacie NX Jour 50 gSupremacie NX Jour 50 gSupremacie NX Jour 50 g ASupremacie NX Jour 50 g A

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
a90f088a-9578-47a2-8f6e-0a9d32aafec6Product name120181030
f6c90bdc-1674-455a-aadd-1b1b59e5edebProduct name220181030
f1ec5c2f-d01e-a277-5826-c7eba86ed99bProduct name120140508

FDA-Initiated Inactive NDC Indexing#

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
43596-0005-0LBEL SUPREMACIE NX JOUR Replenishing Treatment Daytime Face SPF 15 Normal To Dry Skin1 g in 1 POUCHCREAM12
43596-0005-1LBEL SUPREMACIE NX JOUR Replenishing Treatment Daytime Face SPF 15 Normal To Dry Skin5 g in 1 JARCREAM52
43596-0005-2LBEL SUPREMACIE NX JOUR Replenishing Treatment Daytime Face SPF 15 Normal To Dry Skin50 g in 1 JARCREAM502

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
43596-0005LBEL SUPREMACIE NX JOUR REPLENISHING TREATMENT DAYTIME FACE SPF 15 NORMAL TO DRY SKIN (ENSULIZOLE, HOMOSALATE, OCTINOXATE, OXYBENZONE) CREAM [VENTURA CORPORATION, LTD]2Legacy NDC, 3 package rows20120405_c33ba4ab-79a6-4169-9ea3-dfbbe91fcf42.zip

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIISPL versionUploaded
ENSULIZOLEACTIVE INGREDIENT9YQ9DI1W422
HOMOSALATEACTIVE INGREDIENTV06SV4M95S2
OCTINOXATEACTIVE INGREDIENT4Y5P7MUD512
OXYBENZONEACTIVE INGREDIENT95OOS7VE0Y2
ENSULIZOLEACTIVE MOIETY9YQ9DI1W422
HOMOSALATEACTIVE MOIETYV06SV4M95S2
OCTINOXATEACTIVE MOIETY4Y5P7MUD512
OXYBENZONEACTIVE MOIETY95OOS7VE0Y2
ALKYL (C12-15) BENZOATEINACTIVE INGREDIENTA9EJ3J61HQ2
BIOTINOYL TRIPEPTIDE-1INACTIVE INGREDIENTO6380721VA2
BUTYLENE GLYCOLINACTIVE INGREDIENT3XUS85K0RA2
BUTYLPARABENINACTIVE INGREDIENT3QPI1U3FV82
C13-14 ISOPARAFFININACTIVE INGREDIENTE4F12ROE702
CARBOMER INTERPOLYMER TYPE A (55000 MPA.S)INACTIVE INGREDIENT59TL3WG5CO2
CETETH-20INACTIVE INGREDIENTI835H2IHHX2
CETYL ALCOHOLINACTIVE INGREDIENT936JST6JCN2
CHLORELLA VULGARISINACTIVE INGREDIENTRYQ4R60M022
CYCLOMETHICONE 5INACTIVE INGREDIENT0THT5PCI0R2
CYCLOMETHICONE 6INACTIVE INGREDIENTXHK3U310BA2
DIMETHICONEINACTIVE INGREDIENT92RU3N3Y1O2
EDETATE SODIUMINACTIVE INGREDIENTMP1J8420LU2
ERYTHRITOLINACTIVE INGREDIENTRA96B954X62
FD&C BLUE NO. 1INACTIVE INGREDIENTH3R47K3TBD2
FD&C RED NO. 4INACTIVE INGREDIENTX3W0AM1JLX2
FD&C YELLOW NO. 5INACTIVE INGREDIENTI753WB2F1M2
GLYCERININACTIVE INGREDIENTPDC6A3C0OX2
GLYCERYL MONOSTEARATEINACTIVE INGREDIENT230OU9XXE42
ISOBUTYLPARABENINACTIVE INGREDIENT0QQJ25X58G2
LAURETH-23INACTIVE INGREDIENTN72LMW566G2
LAURETH-4INACTIVE INGREDIENT6HQ855798J2
LAURETH-7INACTIVE INGREDIENTZ95S6G82012
METHYLPARABENINACTIVE INGREDIENTA2I8C7HI9T2
PEAINACTIVE INGREDIENTW4X7H8GYFM2
PEG-75 STEARATEINACTIVE INGREDIENTOT38R0N74H2
PHENOXYETHANOLINACTIVE INGREDIENTHIE492ZZ3T2
PROPYLPARABENINACTIVE INGREDIENTZ8IX2SC1OH2
SODIUM POLYSTYRENE SULFONATEINACTIVE INGREDIENT1699G8679Z2
SORGHUM BICOLOR STEM JUICEINACTIVE INGREDIENTSKN30A294R2
STEARETH-20INACTIVE INGREDIENTL0Q8IK9E082
STEARIC ACIDINACTIVE INGREDIENT4ELV7Z65AP2
TRIFOLIUM PRATENSE FLOWERINACTIVE INGREDIENT4JS08388282
TROLAMINEINACTIVE INGREDIENT9O3K93S3TK2
WATERINACTIVE INGREDIENT059QF0KO0R2
XANTHAN GUMINACTIVE INGREDIENTTTV12P4NEE2

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 2 · 42 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
43596-000543596-0005-0, 43596-0005-1, 43596-0005-2

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 2 · 41 matching rows.

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 8 · 459 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredientIID ingredientUNIIDosage form / routePotencyMaximum daily exposureMatch
TROLAMINETROLAMINE9O3K93S3TKINJECTION, POWDER, FOR SUSPENSION / INTRAVENOUS0.02 %w/vExact identifier — unii candidate
22 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXSOLUTION / DENTAL15 %w/vExact identifier — unii candidate
75 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXSUSPENSION / AURICULAR (OTIC)0.05 %w/wExact identifier — unii candidate
75 equally ranked IID candidates
METHYLPARABENMETHYLPARABENA2I8C7HI9TINJECTION / INFILTRATION80 mgExact identifier — unii candidate
79 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXTABLET, COATED / ORAL1 mgExact identifier — unii candidate
75 equally ranked IID candidates
GLYCERYL MONOSTEARATEGLYCERYL MONOSTEARATE230OU9XXE4SUSPENSION / AURICULAR (OTIC)0.5 %w/vExact identifier — unii candidate
21 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXSOLUTION / ORAL32400 mgExact identifier — unii candidate
75 equally ranked IID candidates
METHYLPARABENMETHYLPARABENA2I8C7HI9TSOLUTION, CONCENTRATE / ORAL1 mg/1mlExact identifier — unii candidate
79 equally ranked IID candidates
METHYLPARABENMETHYLPARABENA2I8C7HI9TSUSPENSION / AURICULAR (OTIC)NAExact identifier — unii candidate
79 equally ranked IID candidates
PROPYLPARABENPROPYLPARABENZ8IX2SC1OHINJECTION / INTRALESIONAL0.02 %w/vExact identifier — unii candidate
68 equally ranked IID candidates
FD&C YELLOW NO. 5FD&C YELLOW NO. 5I753WB2F1MTABLET, SUGAR COATED / ORALNAExact identifier — unii candidate
22 equally ranked IID candidates
METHYLPARABENMETHYLPARABENA2I8C7HI9TCAPSULE, EXTENDED RELEASE / ORAL2 mgExact identifier — unii candidate
79 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXSOLUTION/ DROPS / AURICULAR (OTIC)25 mgExact identifier — unii candidate
75 equally ranked IID candidates
TROLAMINETROLAMINE9O3K93S3TKCREAM, AUGMENTED / TOPICAL20 mgExact identifier — unii candidate
22 equally ranked IID candidates
FD&C BLUE NO. 1FD&C BLUE NO. 1H3R47K3TBDPASTE, DENTIFRICE / DENTALNAExact identifier — unii candidate
37 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXSOLUTION / TOPICAL1971 mgExact identifier — unii candidate
75 equally ranked IID candidates
GLYCERYL MONOSTEARATEGLYCERYL MONOSTEARATE230OU9XXE4CAPSULE / ORAL13.75 mgExact identifier — unii candidate
21 equally ranked IID candidates
BUTYLPARABENBUTYLPARABEN3QPI1U3FV8SYRUP / ORAL28.4 mg/1mlExact identifier — unii candidate
15 equally ranked IID candidates
TROLAMINETROLAMINE9O3K93S3TKSOLUTION / TOPICALNAExact identifier — unii candidate
22 equally ranked IID candidates
SODIUM POLYSTYRENE SULFONATESODIUM POLYSTYRENE SULFONATE1699G8679ZSUSPENSION/ DROPS / OPHTHALMIC0.25 %w/vExact identifier — unii candidate
8 equally ranked IID candidates
XANTHAN GUMXANTHAN GUMTTV12P4NEETABLET / ORAL56 mgExact identifier — unii candidate
29 equally ranked IID candidates
METHYLPARABENMETHYLPARABENA2I8C7HI9TSUSPENSION / ORAL388 mgExact identifier — unii candidate
79 equally ranked IID candidates
PROPYLPARABENPROPYLPARABENZ8IX2SC1OHSOLUTION / NASAL140 mgExact identifier — unii candidate
68 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXTABLET, FILM COATED / ORAL1.55 mgExact identifier — unii candidate
75 equally ranked IID candidates
METHYLPARABENMETHYLPARABENA2I8C7HI9TSPRAY / TOPICAL0.2 %w/wExact identifier — unii candidate
79 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXCREAM / VAGINAL60 mgExact identifier — unii candidate
75 equally ranked IID candidates
FD&C YELLOW NO. 5FD&C YELLOW NO. 5I753WB2F1MTABLET, EXTENDED RELEASE / ORAL2.03 mgExact identifier — unii candidate
22 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXCONCENTRATE / ORAL1800 mgExact identifier — unii candidate
75 equally ranked IID candidates
TROLAMINETROLAMINE9O3K93S3TKAEROSOL, METERED / RECTALADJ PHExact identifier — unii candidate
22 equally ranked IID candidates
PROPYLPARABENPROPYLPARABENZ8IX2SC1OHSUSPENSION / RECTAL271 mgExact identifier — unii candidate
68 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXDOUCHE / VAGINAL1 %w/wExact identifier — unii candidate
75 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXINJECTION / INTRADERMAL1.6 %w/vExact identifier — unii candidate
75 equally ranked IID candidates
BUTYLPARABENBUTYLPARABEN3QPI1U3FV8CREAM / TOPICAL0.4 %w/wExact identifier — unii candidate
15 equally ranked IID candidates
PROPYLPARABENPROPYLPARABENZ8IX2SC1OHINJECTION / PARENTERAL2 mgExact identifier — unii candidate
68 equally ranked IID candidates
EDETATE SODIUMEDETATE SODIUMMP1J8420LUSHAMPOO / TOPICAL1.33 %w/wExact identifier — unii candidate
12 equally ranked IID candidates
XANTHAN GUMXANTHAN GUMTTV12P4NEEGRANULE, FOR SUSPENSION, EXTENDED RELEASE / ORAL2350 mgExact identifier — unii candidate
29 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXLIQUID / TOPICAL2.5 %w/wExact identifier — unii candidate
75 equally ranked IID candidates
CETYL ALCOHOLCETYL ALCOHOL936JST6JCNTABLET, ORALLY DISINTEGRATING / ORAL9 mgExact identifier — unii candidate
20 equally ranked IID candidates
FD&C BLUE NO. 1FD&C BLUE NO. 1H3R47K3TBDFILM, SOLUBLE / ORAL0.04 mgExact identifier — unii candidate
37 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXPASTE / ORAL3822 mgExact identifier — unii candidate
75 equally ranked IID candidates
CYCLOMETHICONE 5CYCLOMETHICONE 50THT5PCI0RAEROSOL, FOAM / TOPICAL144 mgExact identifier — unii candidate
3 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXAEROSOL, FOAM / TOPICAL21 mgExact identifier — unii candidate
75 equally ranked IID candidates
PROPYLPARABENPROPYLPARABENZ8IX2SC1OHDROPS / AURICULAR (OTIC)NAExact identifier — unii candidate
68 equally ranked IID candidates
CETYL ALCOHOLCETYL ALCOHOL936JST6JCNSUSPENSION / AURICULAR (OTIC)1 %w/vExact identifier — unii candidate
20 equally ranked IID candidates
STEARIC ACIDSTEARIC ACID4ELV7Z65APSOAP / TOPICAL6 %w/wExact identifier — unii candidate
26 equally ranked IID candidates
PROPYLPARABENPROPYLPARABENZ8IX2SC1OHCONCENTRATE / ORAL2.5 mg/5mlExact identifier — unii candidate
68 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXTABLET / ORAL42 mgExact identifier — unii candidate
75 equally ranked IID candidates
SODIUM POLYSTYRENE SULFONATESODIUM POLYSTYRENE SULFONATE1699G8679ZTABLET, CHEWABLE, EXTENDED RELEASE / ORAL125 mgExact identifier — unii candidate
8 equally ranked IID candidates
EDETATE SODIUMEDETATE SODIUMMP1J8420LUSOLUTION / OPHTHALMIC0.1 %w/vExact identifier — unii candidate
12 equally ranked IID candidates
METHYLPARABENMETHYLPARABENA2I8C7HI9TJELLY / TOPICAL420 mgExact identifier — unii candidate
79 equally ranked IID candidates
TROLAMINETROLAMINE9O3K93S3TKSOLUTION / NASALNAExact identifier — unii candidate
22 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXSYSTEM / TOPICAL18144 mgExact identifier — unii candidate
75 equally ranked IID candidates
PROPYLPARABENPROPYLPARABENZ8IX2SC1OHSPRAY / NASAL0.2 mgExact identifier — unii candidate
68 equally ranked IID candidates
PROPYLPARABENPROPYLPARABENZ8IX2SC1OHGEL / VAGINAL2 mgExact identifier — unii candidate
68 equally ranked IID candidates
LAURETH-4LAURETH-46HQ855798JSOLUTION / TOPICAL5.22 %w/vExact identifier — unii candidate
4 equally ranked IID candidates
TROLAMINETROLAMINE9O3K93S3TKGEL / TRANSDERMAL6 mgExact identifier — unii candidate
22 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXINJECTION, SOLUTION / INTRAMUSCULAR15 %w/vExact identifier — unii candidate
75 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXLIQUID / ORAL2400 mgExact identifier — unii candidate
75 equally ranked IID candidates
PROPYLPARABENPROPYLPARABENZ8IX2SC1OHINJECTION, SUSPENSION / INTRAMUSCULAR0.02 %w/vExact identifier — unii candidate
68 equally ranked IID candidates
EDETATE SODIUMEDETATE SODIUMMP1J8420LUINJECTION / INTRAMUSCULAR0.01 %w/vExact identifier — unii candidate
12 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
28f26674-ce97-4c85-b3a0-392e79366e7fc33ba4ab-79a6-4169-9ea3-dfbbe91fcf422012-03-28WarningsExact identifier
spl id: 28f26674-ce97-4c85-b3a0-392e79366e7f
spl set id: c33ba4ab-79a6-4169-9ea3-dfbbe91fcf42

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.